Brief: Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers
21/08/2024 13:29
Aug 21 (Reuters) - Monopar Therapeutics Inc MNPR.O :
* MONOPAR RECEIVES CLEARANCE TO PROCEED WITH PHASE 1
THERAPEUTIC
TRIAL OF NOVEL RADIOPHARMACEUTICAL IN ADVANCED CANCERS
* MONOPAR THERAPEUTICS INC - MNPR-101-LU SHOWS PROMISING
RESULTS
IN PRECLINICAL STUDIES
Source text for Eikon: ID:nGNX3PJCHL
Further company coverage: MNPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Monopar Therapeutics
See all newsBrief: Monopar Appoints Jeffrey D. Kent, M.D., As Executive Vice President, Head Of Medical Affairs Announces Two Alxn1840 Presentations At Aasld – The Liver Meeting 2026
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Monopar Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Monopar Therapeutics Inc. expected to post a loss of 62 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alphabet, IBM, Tesla